Baxter International Inc

BAX

16.845USD

+0.235+1.41%

Market hours （ET）Quotes delayed by 15 min

Baxter International Inc's Score

Industry at a Glance

Industry Ranking

59 / 209

Overall Ranking

150 / 4547

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Baxter International Inc Highlights

StrengthsRisks

Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.

Fairly Valued

The company’s latest PE is -8.96, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 527.76M shares, increasing 0.01% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 2.40K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.67.

Analyst Rating

Based on 18 analysts

Hold

Current Rating

21.522

Target Price

+33.26%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Baxter International Inc is 7.08, ranking 92 out of 209 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 2.97B, representing a year-over-year increase of 8.03%, while its net profit experienced a year-over-year increase of 120.31%.

Score

Industry at a Glance

Previous score

7.08

Change

0



Financials

5.93

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

5.90

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.11

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

6.31

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

9.14

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of Baxter International Inc is 8.27, ranking 33 out of 209 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -8.96, which is -2070.17% below the recent high of 176.58 and -1044.24% above the recent low of -102.55.

Score

Industry at a Glance

Previous score

8.27

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 59/209

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Baxter International Inc is 6.11, ranking 174 out of 209 in the Healthcare Equipment & Supplies industry. The average price target is 22.00, with a high of 48.01 and a low of 15.00.

Score

Industry at a Glance

Previous score

6.11

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Baxter International Inc is 6.51, ranking 137 out of 209 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 19.89 and the support level at 14.81, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.59

Change

-0.08

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-03-24

The current institutional shareholding score of Baxter International Inc is 10.00, ranking 1 out of 209 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 108.76%, representing a quarter-over-quarter decrease of 1.17%. The largest institutional shareholder is Richard Pzena, holding a total of 70.05M shares, representing 13.61% of shares outstanding, with 90.00% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Pzena Investment Management, LLC

Star Investors

57.39M

+3.48%

The Vanguard Group, Inc.

Star Investors

62.26M

+0.49%

Dodge & Cox

Star Investors

57.40M

+10.12%

BlackRock Institutional Trust Company, N.A.

31.32M

+4.95%

BlackRock Financial Management, Inc.

24.69M

+31.81%

Fidelity Management & Research Company LLC

11.93M

+200.31%

State Street Investment Management (US)

22.00M

+0.27%

Geode Capital Management, L.L.C.

12.54M

-2.68%

Greenhaven Associates, Inc.

10.69M

+70.05%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Baxter International Inc is 6.65, ranking 55 out of 209 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.62. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Baxter International Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.

Baxter International Inc

BAX

7.20 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Anika Therapeutics Inc

ANIK

8.62 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

8.46 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Bioventus Inc

BVS

8.32 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

LeMaitre Vascular Inc

LMAT

8.22 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

West Pharmaceutical Services Inc

WST

8.19 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment